Centre for Operative Medicine, Department of Surgery I, University of Würzburg, Germany.
HPB (Oxford). 2007;9(4):302-7. doi: 10.1080/13651820701348621.
The appropriate management of the pancreatic remnant following distal pancreatic resection remains a clinically relevant problem. We carried out a retrospective analysis which focused on this issue and compared the two favored techniques of suture and staple closure.
Forty-six patients underwent distal pancreatectomy between October 1999 and January 2006. The patients were retrospectively analysed based on the management of the remaining pancreatic gland. Thirty-seven patients had suture and nine patients had staple closure. The morbidity, mortality, incidence of pancreatic fistula, necessity of secondary surgical intervention, and the duration of hospital stay for the two groups were compared. Pancreatic fistula was considered according to the novel international standard definition (ISGPF). In addition, subgroup analysis of patients receiving octreotide was carried out.
Overall, postoperative morbidity due to pancreatic fistula occurred in seven patients (19%) after suture and in one patient (11%) after staple closure (p = 0.54), with no deaths. The number of patients with surgical revision related to pancreatic leakage was two (5%) after suture closure vs no revision after staple closure (p = 0.65). The median number of total hospital days for the suture group was 19 (range 7-78 days) vs 21 (range 12-96 days) for the stapler group (p = 0.21). No significant benefit for the octreotide application could be determined.
According to the data, no significant difference for either suture or stapler closure was observed, with the tendency for staple closure to be superior.
远端胰腺切除术后胰腺残端的适当处理仍然是一个具有临床意义的问题。我们进行了一项回顾性分析,重点关注这个问题,并比较了缝合和吻合器两种常用的闭合技术。
1999 年 10 月至 2006 年 1 月期间,有 46 例患者接受了远端胰腺切除术。根据剩余胰腺的处理方式,对这些患者进行了回顾性分析。其中 37 例采用缝合,9 例采用吻合器。比较两组患者的发病率、死亡率、胰瘘发生率、是否需要二次手术干预以及住院时间。根据新的国际标准定义(ISGPF)判断胰瘘。此外,还对接受奥曲肽治疗的患者进行了亚组分析。
总的来说,缝合组术后因胰瘘导致的并发症发生率为 7 例(19%),吻合器组为 1 例(11%)(p=0.54),无死亡病例。缝合组需要手术修复与胰漏相关的患者有 2 例(5%),而吻合器组无患者需要修复(p=0.65)。缝合组的总住院天数中位数为 19 天(范围 7-78 天),吻合器组为 21 天(范围 12-96 天)(p=0.21)。奥曲肽的应用没有明显的获益。
根据这些数据,缝合和吻合器闭合的效果没有明显差异,吻合器闭合的效果有一定优势。